Insulin Lispro Protamine + Insulin Lispro: Brands, Price & Uses in Bangladesh

Insulin Lispro Protamine + Insulin Lispro is a premixed biphasic insulin analog formulation indicated for the treatment of diabetes mellitus in patients who require insulin for control of hyperglycemia.

Established / FDA-approved uses

• Type 2 diabetes mellitus: Improve glycemic control in adults who require insulin therapy, typically after oral antidiabetic agents alone are inadequate. This is the primary approved use.
• Type 1 diabetes mellitus: As part of an insulin regimen for glycemic control, although Insulin Lispro Protamine + Insulin Lispro is generally less flexible than basal-bolus regimens because the intermediate-to-rapid-acting ratio is fixed.

Guideline-supported use

• Used as a twice-daily premixed insulin option in stepwise insulin intensification per diabetes management guidelines, generally in patients whose lifestyle favors a simpler fixed-ratio regimen over multiple daily basal-bolus injections.

Insulin Lispro Protamine + Insulin Lispro is not indicated for the treatment of diabetic ketoacidosis; a rapid-acting, short-duration intravenous insulin is preferred in that setting.

General dosing principles

The dose of Insulin Lispro Protamine + Insulin Lispro must be individualized by the treating physician based on blood glucose monitoring results, meal pattern, activity level, and glycemic targets. There is no fixed standard dose.

Adult dosing

• Typically administered twice daily, within 15 minutes before or immediately after breakfast and the evening meal, as part of a comprehensive insulin regimen.
• Total daily insulin requirements generally range from 0.5–1 unit/kg/day, divided per the prescribed regimen, but this varies substantially between patients and must be titrated individually.
• When transferring from another insulin product or premixed ratio, initiation and dose adjustment must be done under close medical supervision with frequent blood glucose monitoring, as errors can lead to severe hypoglycemia or hyperglycemia.

Pediatric dosing

Safety and effectiveness of Insulin Lispro Protamine + Insulin Lispro in pediatric patients have not been well established; use in children requires specialist supervision and individualized dosing (see Use in Special Populations).

Renal or hepatic impairment

Insulin requirements may be reduced in patients with renal or hepatic impairment due to altered insulin clearance and metabolism. Dose reduction and more frequent blood glucose monitoring are recommended in these patients.

Administration technique

• For subcutaneous injection only — into the abdomen, thigh, buttock, or upper arm, with rotation of injection sites to reduce the risk of lipodystrophy.
• Must NOT be given intravenously or intramuscularly, and must NOT be used in an external or implanted insulin pump.
• Because it is a suspension, the vial or pen must be gently rolled and inverted (not shaken) until uniformly white and cloudy before each dose is drawn or dialed.
• Insulin Lispro Protamine + Insulin Lispro is a fixed premix and must not be diluted or mixed with any other insulin product.

The most common and clinically important adverse effect of Insulin Lispro Protamine + Insulin Lispro is hypoglycemia, which is discussed fully under Precautions and Warnings and Overdose Effects. Other adverse effects reported with Insulin Lispro Protamine + Insulin Lispro include:

• Injection-site reactions: pain, redness, swelling, itching, or lipodystrophy (thickening or pitting of fat) at frequently reused injection sites.
• Allergic reactions: localized rash or urticaria at the injection site; rarely, generalized allergic reactions including anaphylaxis.
• Weight gain, associated with the anabolic and glucose-lowering effects of insulin.
• Peripheral edema, particularly on initiation of insulin therapy or with intensified glycemic control.
• Hypokalemia (low blood potassium), particularly if not monitored in at-risk patients.
• Lipodystrophy or cutaneous amyloidosis at injection sites with repeated use at the same location.